Onychomycosis Treatment Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis

The Onychomycosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Onychomycosis Treatment Market Size and Its Estimated Growth Rate?
In the past few years, the market size for onychomycosis treatment has seen substantial growth. It is projected to increase from $3.65 billion in 2024 to $3.92 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.4%. This prior growth is linked to factors such as the rise in fungal infections, an aging demographic, growing public knowledge of the condition, an increase in the incidence of onychomycosis, and heightened disposable incomes.

The market for onychomycosis treatments is projected to experience robust growth over the next several years, expanding to $5.09 billion by 2029 with a compound annual growth rate (CAGR) of 6.7%. This anticipated growth during the forecast period is likely to be driven by elements such as an rising elderly population, the broadening scope of telemedicine, the emergence of combination therapies, better access to healthcare, shifts in lifestyles and external conditions, along with a growing prevalence of diabetes. The forecast period is also expected to be characterized by key trends like progress in dermatology, innovative drug delivery methods, tailor-made treatment plans, advancements in topical treatments, digital health solutions, along with the use of laser therapy.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12941

How Are Emerging Segments Shaping the Onychomycosis Treatment Market Landscape?
The onychomycosis treatment market covered in this report is segmented -

1) By Type: Distal Sublingual Onychomycosis, White Superficial Onychomycosis, Proximal Sublingual Onychomycosis, Candida Onychomycosis, Other Types
2) By Treatment Type: Drugs, Laser Therapy, Photodynamic Therapy
3) By Age Group: 0 To 18 Years, 18 To 39 Years, 40 To 64 Years, 65 Years And Above
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12941&type=smp

Which Growth Factors Are Influencing Onychomycosis Treatment Market Expansion?
The rise in fungal infections is projected to stimulate the expansion of the onychomycosis therapy market. Such infections are microbial ailments resulting from various fungi that affect different body parts and lead to specific conditions. Onychomycosis, a fungal disease of the nails, is typically addressed with oral or topical antifungal drugs that eradicate the fungal growth and promote healthy nail development. For instance, the UK Health Security Agency recorded 2,265 instances of bloodstream infections (BSI) provoked by yeast in England in 2022, with the overall rate of BSI due to yeast slightly increasing to 4.0 per 100,000 population from 3.8 per 100,000 the previous year. Candida albicans, Nakaseomyces glabratus, and Candida parapsilosis were the three most frequently identified yeast species in blood samples. Hence, the rise in fungal infections is accelerating the growth of the onychomycosis treatment market. Onychomycosis Treatment Market Driver: Diabetes Cases Increases Growth In Onychomycosis Treatment Market

Who Are the Dominant Players Across Different Onychomycosis Treatment Market Segments?
Major companies operating in the onychomycosis treatment market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Hetero Drugs Ltd., Sun Pharmaceutical Industries Limited, Cadila Pharmaceuticals Ltd., Dr. Reddys Laboratories Ltd., Intas Pharmaceuticals Limited, Cipla Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Aurobindo Pharma Limited, Alkem Laboratories Limited, Jubilant Life Sciences Ltd., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Biocon Limited, Emcure Pharmaceuticals Limited, Alembic Pharmaceuticals Ltd., Laurus Labs Limited, Strides Pharma Science Limited, Aarti Drugs Ltd., NATCO Pharma Ltd., Unichem Laboratories Ltd., Indoco Remedies Ltd., Apex Laboratories Pvt. Ltd., Wockhardt Ltd., Nuray Chemicals Private Limited.

What Are the Latest Developing Trends in the Onychomycosis Treatment Market?
Key players in the market for onychomycosis treatment are prioritizing the development and approval of novel products, such as MOB-015, to stay competitive. For instance, Moberg Pharma AB, a pharmaceutical company based in Sweden, got the green light for MOB-015 in the European Union in June 2023 for use against mild to moderate adult nail fungal infections. This authorization by the EU marked the first global approval for this innovative drug for onychomycosis. Evidence from two Phase 3 studies confirmed an improved mycological cure rate (76% compared to up to 42% for similar drugs) and a significantly higher total cure rate than the control group, all without any serious negative side-effects. The topical terbinafine formula, MOB-015, enables effective terbinafine levels to reach the nail and underlying nail bed without the dangers linked to systemic exposure from oral terbinafine treatment.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/onychomycosis-treatment-global-market-report

Which Geographic Regions Are Expected to Dominate the Onychomycosis Treatment Market in the Coming Years?
North America was the largest region in the onychomycosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in onychomycosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Onychomycosis Treatment Market?
2. What is the CAGR expected in the Onychomycosis Treatment Market?
3. What Are the Key Innovations Transforming the Onychomycosis Treatment Industry?
4. Which Region Is Leading the Onychomycosis Treatment Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.